Loading clinical trials...
Loading clinical trials...
This study is a longer-term follow-up study for patients who have been administered AAV2/5-OPTIRPE65 in the Phase I/II, open label, non-randomised, two-centre, dose escalation trial in adults and chil...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
MeiraGTx UK II Ltd
NCT07322302 · Trachoma, Eye Diseases, and more
NCT05414994 · Microbial Colonization, Eye Diseases, and more
NCT07228793 · Retinitis Pigmentosa, Eye Diseases
NCT06177639 · Eye Diseases
NCT05147701 · Eye Diseases, Retinitis Pigmentosa, and more
Kellogg Eye Center, University of Michigan Health
Ann Arbor, Michigan
Moorfields Eye Hospital NHS Foundation Trust
London
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions